What is the price target for OCGN stock?
13 analysts have analysed OCGN and the average price target is 11.37 USD. This implies a price increase of 514.87% is expected in the next year compared to the current price of 1.8485.
OCUGEN INC (OCGN) Forecast, Price Target & Analyst Ratings
NASDAQ:OCGN • US67577C1053
Current stock price
1.8485 USD
-0.14 (-7.11%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for OCUGEN INC (OCGN).
Forecast Snapshot
Next Earnings Forecast
Earnings Estimate- Release Date
- May 1, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 550.8K
Price Target Details & History
Consensus Price Target and Range
Mean target
$11.37
Upside
+ 514.86%
From current price of $1.85 to mean target of $11.37, Based on 13 analyst forecasts
Low
$7.07
Median
$10.20
High
$23.10
Price Target Revisions
1 Month
23.81%
3 Months
23.81%
Price Target Summary
13 Wall Street analysts provided a forecast for the next 12 months for OCGN. The average price target is 11.37 USD. This implies a price increase of 514.87% is expected in the next year compared to the current price of 1.8485.
The average price target has been revised upward by 23.81% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
83.08%
OCGN was analyzed by 13 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about OCGN.
In the previous month the buy percentage consensus was at a similar level.
OCGN was analyzed by 13 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-25 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-03-25 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2026-03-17 | Canaccord Genuity | Initiate | Buy |
| 2026-03-11 | Oppenheimer | Initiate | Outperform |
| 2026-03-05 | Chardan Capital | Maintains | Buy -> Buy |
| 2026-01-20 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-09-19 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-08-04 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-06-24 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-12 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-12 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-03-06 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-03-06 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-02-13 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-02-13 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-01-23 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-01-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-18 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-11-14 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-11 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-08 | Chardan Capital | Maintains | Buy -> Buy |
| 2024-10-23 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-10-15 | Maxim Group | Initiate | Buy |
| 2024-05-15 | Chardan Capital | Maintains | Buy -> Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 1, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.05
- Revenue Estimate
- 550.8K
- Revenue Q2Q
- -62.81%
- EPS Q2Q
- -7.83%
- Number of Analysts
- 9
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
3.33%
Next Earnings Summary
OCGN is expected to report earnings on 5/1/2026. The consensus EPS estimate for the next earnings is -0.05 USD and the consensus revenue estimate is 550.80K USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 6.036M | 4.055M -32.82% | 4.413M 8.83% | 2.203M -50.08% | 40.059M 1,718.38% | 174.64M 335.96% | 1.049B 500.66% | 1.709B 62.92% | 2.643B 54.65% | 3.385B 28.07% | 3.853B 13.83% | |
| EBITDA YoY % growth | -64.827M 23.18% | -52.789M 18.57% | -60.527M -14.66% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -65.531M 22.79% | -54.757M 16.44% | -62.916M -14.90% | -77.122M -22.58% | -55.909M 27.51% | 25.029M 144.77% | 522.03M 1,985.70% | 887.81M 70.07% | 1.573B 77.18% | 1.935B 23.01% | 2.241B 15.81% | |
| Operating Margin | -1,085.67% | -1,350.36% | -1,425.70% | -3,500.79% | -139.57% | 14.33% | 49.76% | 51.95% | 59.52% | 57.16% | 58.16% | |
| EPS YoY % growth | -0.24 36.84% | -0.19 20.83% | -0.23 -21.05% | -0.23 1.17% | -0.20 11.15% | 0.02 107.58% | 0.86 5,500.00% | 1.36 58.33% | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.05 -7.83% | -0.05 -7.83% | -0.06 18.82% | -0.06 0.43% | -0.06 -13.51% | -0.06 -13.51% | 0.05 189.75% | 0.19 424.40% |
| Revenue Q2Q % growth | 550.8K -62.81% | 550.8K -59.88% | 550.8K -68.56% | 550.8K 385.39% | -100.00% | -100.00% | 48.82M 8,763.47% | 113.91M 20,580.83% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -16.831M -16.06% | -17.295M -25.37% | -17.968M -1.95% | -18.433M 2.03% | -19.177M -13.94% | -20.011M -15.71% | 17.378M 196.71% | 68.618M 472.26% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
27.37%
EPS Next 5 Year
51.18%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
216.47%
Revenue Next 5 Year
215.01%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
OCUGEN INC / OCGN Forecast FAQ
What is the next earnings date for OCGN stock?
OCUGEN INC (OCGN) will report earnings on 2026-05-01.
What are the consensus estimates for OCUGEN INC (OCGN) next earnings?
The consensus EPS estimate for the next earnings of OCUGEN INC (OCGN) is -0.05 USD and the consensus revenue estimate is 550.80K USD.
What is the expected long term growth rate for OCUGEN INC (OCGN)?
The expected long term growth rate for OCUGEN INC (OCGN) is 216.47%.